Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 30,014 $ 36,456
Restricted cash 15,466 13,069
Accounts receivable, net of allowance for credit losses of $85 and $105, respectively 58,729 68,655
Inventories 52,611 66,628
Derivative instruments 2,412 4,973
Other current assets 9,538 9,340
Total current assets 168,770 199,121
Property and equipment, net 248,748 239,069
Other Assets:    
Right of use operating lease assets, net 22,597 18,937
Intangible assets, net 8,498 9,087
Goodwill 5,970
Other assets 5,628 6,137
Total other assets 36,723 40,131
Total Assets 454,241 478,321
Current Liabilities:    
Accounts payable 20,752 28,115
Accrued liabilities 20,205 26,556
Current portion – operating leases 4,333 3,849
Derivative instruments 13,849 6,732
Other current liabilities 6,149 12,765
Total current liabilities 65,288 78,017
Long-term debt, net 82,097 68,356
Operating leases, net of current portion 19,029 15,062
Other liabilities 8,270 8,797
Total Liabilities 174,684 170,232
Commitments and contingencies (Notes 1, 9, 10, 11 and 15)
Stockholders’ Equity:    
Preferred stock value
Common stock, value 76 75
Additional paid-in capital 1,040,912 1,040,834
Accumulated other comprehensive income 2,481 1,822
Accumulated deficit (763,913) (734,643)
Total stockholders’ equity 279,557 308,089
Total Liabilities and Stockholders’ Equity 454,241 478,321
Series A Preferred Stock    
Stockholders’ Equity:    
Preferred stock value
Series B Preferred Stock    
Stockholders’ Equity:    
Preferred stock value 1 1
Non-voting common stock    
Stockholders’ Equity:    
Common stock, value